From: Feeding critically ill patients the right ‘whey’: thinking outside of the box. A personal view
Organ system | Potential adverse effect |
---|---|
Muscle | Decreased skeletal muscle synthesis |
Endocrine | Decreased secretion of GIP, GLP-1, peptide YY and CCK |
Decreased insulin release | |
Insulin resistance | |
Hyperglycemia | |
Gastrointestinal | Hepatic steatosis |
Hepatic inflammation | |
Enlarged non-contractile gall bladder | |
Impaired lipid absorption | |
Small bowel atrophy | |
Impaired small bowel function | |
Decreased mesenteric blood flow | |
Other | Multi-organ dysfunction syndrome |